Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/VRTX
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Vertex Pharmaceuticals Incorporated (VRTX) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Vertex Pharmaceuticals (VRTX) trades at $514.43, down 1.28% in the session, with a bullish technical signal despite recent volatility. The company reported strong 2025 results with $12.0B revenue and $4.0B net income, though recent quarters show mixed EPS performance. Key developments include the acquisition of Crinetics Pharmaceuticals, expanding its therapeutic pipeline and executive leadership.
Outlook remains positive with Wall Street consensus Buy rating (85.7%) and $549.90 price target, supported by robust profitability and growth initiatives. Risks include competitive pressures in core markets and integration challenges from acquisitions. The stock offers upside potential but requires monitoring of earnings consistency and market sentiment shifts.
Read full analysis

Key Stats

  • Market Cap
    $130.42B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $557.96
  • 52W Low
    $376.62
  • Typical Hold Time
    -
  • Enterprise Value
    $124.55B
  • Div Yield
    -
  • Trading Activity
    -
$516.48
52W Low: $376.62
24 Sep 2025
52W High: $557.96
03 Sep 2026

Track Vertex Pharmaceuticals Incorporated (VRTX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Vertex Pharmaceuticals Incorporated has traded between a low of $376.62 and a high of $557.96, highlighting its annual price range. Buy and sell Vertex Pharmaceuticals Incorporated shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

Most Recent News

Content is generated by Aura AI

NYSE expands in Texas amid rising competition from Texas Stock Exchange and corporate relocations.

The New York Stock Exchange (NYSE) is expanding its presence in Texas by opening its NYSE Texas headquarters in Dallas, where it already lists about 130 companies. This move comes as the newly launched Texas Stock Exchange gains major corporate listi...

Market News
4 hours ago
Fox Business
Bullish
news icon
NYSE expands in Texas amid rising competition from Texas Stock Exchange and corporate relocations.

Storage stocks Seagate and SanDisk fall on profit taking; Micron holds steady amid AI-driven memory demand.

Seagate and SanDisk stocks dropped 4% and 3% respectively due to profit taking after strong gains this year, with no new company news to explain the decline. Seagate shares have surged 201% year-to-date, while SanDisk rose 29% in the past month. In c...

Market News
4 hours ago
24/7 Wall Street
Neutral
Storage stocks Seagate and SanDisk fall on profit taking; Micron holds steady amid AI-driven memory demand.

Coordinated yen interventions unwind carry trades, raising market risk and favoring gold and Bitcoin hedges.

Recent coordinated interventions by the U.S. and Japan have strengthened the yen, reversing over $2 trillion in carry trades and increasing market risk. Unlike the August 2024 sell-off, this move is well-telegraphed with efforts to avoid disorder thr...

Market News
4 hours ago
Seeking Alpha
Neutral
Coordinated yen interventions unwind carry trades, raising market risk and favoring gold and Bitcoin hedges.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $130.42B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $557.96
  • 52W Low
    $376.62
  • Typical Hold Time
    -
  • Enterprise Value
    $124.55B
  • Div Yield
    -
  • Trading Activity
    -
$516.48
52W Low: $376.62
24 Sep 2025
52W High: $557.96
03 Sep 2026

Track Vertex Pharmaceuticals Incorporated (VRTX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Vertex Pharmaceuticals Incorporated has traded between a low of $376.62 and a high of $557.96, highlighting its annual price range. Buy and sell Vertex Pharmaceuticals Incorporated shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!